Verhoef M J, Hilsden R J, O'Beirne M
Department of Community Health Sciences, University of Calgary, Faculty of Medicine, 3330 Hospital Drive NW, Calgary, AB, Canada T2N 4N1.
Patient Educ Couns. 1999 Oct;38(2):93-100. doi: 10.1016/s0738-3991(99)00056-7.
The use of complementary therapies by patients with cancer is increasingly common, despite limited evidence for their efficacy and safety. The widespread use of complementary therapies has major implications for research and practice. In this paper, we provide an overview of the current state of knowledge regarding issues related to the use of complementary therapies by patients with cancer. So far, complementary therapies have not been defined very well, which makes it difficult to assess the precise extent of their use. The difference in philosophy underlying conventional and complementary treatments appears to contribute to the attractiveness of complementary therapies. Conventional medical practitioners are beginning to recognize the importance of many of the elements of this philosophy, which is evidenced in the patient-centered model. Explaining how patients with cancer make the decision to use complementary therapies has been the subject of many studies. However, as yet, no formal theory of decision making has been developed. Communication between patients and physicians about complementary therapies is an important part of the patients' decision-making process. Many gaps can be identified in knowledge of complementary therapy use by patients with cancer. Not only is there a need to increase knowledge by conducting more research and improving the research infrastructure, but attention should also be paid to information dissemination, education, and planning and development of health policies.
尽管癌症患者使用补充疗法的疗效和安全性证据有限,但这种情况越来越普遍。补充疗法的广泛使用对研究和实践具有重大影响。在本文中,我们概述了目前关于癌症患者使用补充疗法相关问题的知识现状。到目前为止,补充疗法尚未得到很好的定义,这使得难以评估其确切的使用范围。传统治疗与补充治疗背后理念的差异似乎促成了补充疗法的吸引力。传统医学从业者开始认识到这种理念中许多要素的重要性,这在以患者为中心的模式中得到了体现。解释癌症患者如何做出使用补充疗法的决定一直是许多研究的主题。然而,到目前为止,尚未形成正式的决策理论。患者与医生之间关于补充疗法的沟通是患者决策过程的重要组成部分。在癌症患者使用补充疗法的知识方面可以发现许多空白。不仅需要通过开展更多研究和改善研究基础设施来增加知识,还应关注信息传播、教育以及卫生政策的规划与制定。